BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 2001
View Archived Issues
Novel inhibitors of p53 available from NIH for several therapeutic indications
Read More
Biologically active macrolides available for licensing from NIH
Read More
New dose of Teveten now available in Canada
Read More
Shire reports positive phase III results for SLI-381 in ADHD
Read More
Provigil has beneficial effects in depression; marketing and distribution agreement announced
Read More
Excellent efficacy reported for new triazole KP-103 in superficial fungal infections
Read More
Antiangiogenic effects of KR-31372 demonstrated in rats
Read More
Binding and functional activity of first selective OX1 receptor antagonist characterized
Read More
Biosearch Italia may reacquire rights to ramoplanin; IntraBiotics focuses on iseganan
Read More
Antiatherosclerotic effects of ACAT inhibitor avasimibe confirmed in ApoE*3-Leiden mice
Read More
M&E Biotech now Pharmexa
Read More
Genaera's squalamine receives orphan drug status in U.S.
Read More
ATS 2001: preclinical and clinical findings support development of roflumilast in asthma, COPD
Read More
Synergies between CT-3 and opioids to be studied
Read More
Icos and Texas Biotechnology initiate phase II/III trial of sitaxsentan in pulmonary hypertension
Read More
Expanded potential of CI-1042, a replication-selective adenovirus targeting p53, emerges at ASCO
Read More
Demegen anticipates IND submission for infected burn/wound treatment
Read More
Purine derivatives identified as adenosine A2A agonists at Pfizer
Read More
Lilly presents new compounds for reversing MDR
Read More
Caspase 3 inhibitors from Merck Frosst active in rat model of myocardial ischemia
Read More
Highly selective factor Xa inhibitors emerge from R&D at Corvas
Read More
Protherics designs new tryptase inhibitors particularly useful in asthma Rx
Read More
Monoamine reuptake inhibitors and uses thereof disclosed by Pfizer team
Read More
Recent patent covers new MMP inhibitors developed at Sankyo
Read More
